Plain-English translation of NCT06504147 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new treatment called ®, which is a radioactive substance injected directly into the abdomen to treat advanced ovarian cancer. The study includes women whose cancer has spread in the abdomen and who are already scheduled for chemotherapy and surgery. Researchers want to see if adding this single injection improves outcomes and is safe.
Most women with advanced ovarian cancer have cancer cells spread throughout their abdomen, which is difficult to treat completely. This trial exists to see if this medication, delivered directly to where the cancer is, can help prevent the cancer from coming back after standard chemotherapy and surgery.
You likely qualify if…
You likely don't qualify if…
You would first receive chemotherapy and surgery according to your standard cancer treatment plan. During or after your surgery, you would receive a single injection of the medication directly into your abdomen. The trial has two parts: a small safety group first, then a larger randomized group where you might receive the injection or standard care alone. You would then be monitored with regular clinic visits, blood tests, and imaging scans to check how you are doing.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Belgium
Italy
Norway
Spain